what is alivus life sciences

Alivus Life Sciences Limited is a subsidiary of Nirma Limited, operating as a leading API manufacturer with a focus on specialized, high-value ingredients in key therapeutic segments.

who owns alivus life sciences

Alivus Life Sciences Limited is owned by Nirma Limited, a diversified Indian conglomerate involved in sectors like consumer goods, chemicals, and pharmaceuticals.

Alivus Life Sciences Limited's share price is currently ₹1,067, with a market capitalization of ₹13,087 crore, a P/E ratio of 23.3, book value of ₹246, dividend yield of 0.47%, and a ROCE of 24.9.

Alivus Life Sciences Limited (ALIVUS) Share Price Today — ₹1,030.05

Alivus Life Sciences Limited (ALIVUS) live stock price is ₹1,030.05. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Alivus Life Sciences Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Alivus Life Sciences Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

ALIVUS

BSE

Alivus Life Sciences Limited

Healthcare· Pharmaceuticals & Biotechnology· INE03Q201024· Scrip: 543322

EN हिन्दी ગુજરાતી मराठी

₹1,030.05

▲ 4.60 (+0.00%)

2026-06-10

BSE

₹1,030.05

▲ 4.60

+0.00%

228 trading days · 1Y period

TODAY (BSE)

Open1,041.95

High1,052.00

Low1,022.90

Prev Close1,034.65

Volume36,596

Value₹3.8Cr

L: 1,022.90H: 1,052.00

Info

Face Value₹2

Listed2021-08-06

ISININE03Q201024

SeriesA

BSE Scrip543322

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue+26.63%

PAT+43.69%

EPS+43.70%

Profitability

EBITDA Margin38.8%

Net Margin21.3%

TTM EBITDA M.35.4%

TTM Net M.19.4%

Dividend

Yield—

Latest DPS₹5

Payout Ratio44.7%

Growth-77.78%

TTM Revenue

₹2274 Cr

TTM EBITDA

₹804 Cr

TTM PAT

₹442 Cr

TTM EPS

₹36.05

Rev/Share

₹185.3

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	642 Cr	467 Cr	249 Cr	185 Cr	137 Cr	₹11.18
2024-09-30	507 Cr	388 Cr	175 Cr	127 Cr	95 Cr	₹7.78
2024-06-30	589 Cr	444 Cr	204 Cr	150 Cr	111 Cr	₹9.10
2024-03-31	537 Cr	410 Cr	176 Cr	130 Cr	98 Cr	₹7.99
2023-12-31	573 Cr	414 Cr	216 Cr	161 Cr	119 Cr	₹9.69
2023-09-30	595 Cr	442 Cr	213 Cr	159 Cr	119 Cr	₹9.69
2023-06-30	578 Cr	398 Cr	242 Cr	182 Cr	135 Cr	₹11.05
2023-03-31	621 Cr	427 Cr	261 Cr	198 Cr	146 Cr	₹11.94

Shareholding Pattern

CURRENT — 2026-03-31

Promoter74.9%

FII5.3%

DII7.3%

Public25.1%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-09-01	Dividend	Dividend - Rs 5 Per Share
2023-10-17	Dividend	Interim Dividend - Rs 22.50 Per Share
2023-09-22	Other	Annual General Meeting
2023-03-24	Dividend	Interim Dividend - Rs 21 Per Share
2022-09-15	Dividend	Dividend - Rs 10.5 Per Share
2021-11-22	Dividend	Interim Dividend - Rs 10.50 Per Share

Earnings Transcripts

Alivus Life Sciences Limited has informed the Exchange about Transcript of Earnings Call.

21 May 2026NSE48K chars

Read →

Alivus Life Sciences Limited has informed the Exchange about Schedule of Investors/Analyst Meeting.

20 May 2026NSE2K chars

Read →

Alivus Life Sciences Limited has informed the Exchange about Schedule of Investors/Analyst Meeting.

19 May 2026NSE2K chars

Read →

Alivus Life Sciences Limited has informed the Exchange about Link of Earnings Call Recording

15 May 2026NSE1K chars

Read →

Alivus Life Sciences Limited has informed the Exchange about Investor Presentation

14 May 2026NSE20K chars

Read →

Alivus Life Sciences Limited has informed the Exchange about Schedule of meet - Earnings Call.

8 May 2026NSE2K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	1,035.00	1,053.00	1,022.20	1,031.40	96,314
2026-06-03	1,059.30	1,074.40	1,029.60	1,038.10	74,623
2026-05-27	1,090.70	1,110.40	1,065.70	1,070.30	64,789
2026-05-26	1,066.00	1,124.90	1,057.50	1,090.70	1.59L
2026-05-25	1,039.50	1,066.90	1,031.80	1,049.70	1.08L
2026-05-22	1,073.20	1,073.20	1,030.40	1,039.00	84,154
2026-05-21	1,069.10	1,074.30	1,048.30	1,056.50	38,056
2026-05-20	1,066.00	1,079.30	1,052.10	1,060.80	66,607
2026-05-19	1,055.30	1,074.90	1,050.20	1,061.60	48,645
2026-05-18	1,035.10	1,060.00	1,022.10	1,055.30	1.02L
2026-05-15	1,060.00	1,076.00	1,031.60	1,044.60	2.18L
2026-05-14	1,099.00	1,111.80	1,056.00	1,064.10	81,151
2026-05-13	1,098.00	1,110.00	1,077.70	1,080.80	53,120
2026-05-12	1,119.40	1,127.90	1,092.30	1,098.80	64,605
2026-05-11	1,122.90	1,148.40	1,069.90	1,126.00	86,957
2026-05-08	1,129.00	1,133.50	1,114.30	1,121.30	60,208
2026-05-07	1,135.00	1,138.10	1,106.90	1,121.10	1.48L
2026-05-06	1,090.00	1,134.00	1,068.80	1,125.00	2.23L
2026-05-05	1,060.80	1,092.20	1,060.80	1,076.60	1.02L
2026-05-04	1,040.00	1,081.70	1,036.50	1,069.20	1.35L
2026-04-30	1,006.00	1,063.80	1,005.60	1,038.15	1.97L
2026-04-29	1,008.00	1,029.40	994.30	1,005.50	3.12L
2026-04-28	1,044.95	1,059.80	1,000.50	1,007.65	1.98L
2026-04-27	1,047.90	1,086.00	1,042.10	1,044.95	57,536
2026-04-24	1,060.00	1,077.95	1,039.70	1,050.05	53,727
2026-04-23	1,053.10	1,096.00	1,052.25	1,061.55	43,072
2026-04-22	1,073.15	1,081.90	1,055.00	1,056.85	29,679
2026-04-21	1,069.35	1,088.00	1,042.25	1,073.15	1.56L
2026-04-20	1,060.00	1,069.95	1,038.75	1,068.05	87,350
2026-04-17	1,071.20	1,079.50	1,060.00	1,069.65	2.15L

Frequently Asked Questions

About

Alivus Life Sciences Limited, formerly known as Glenmark Life Sciences, is a leading Indian pharmaceutical company focused on the development and manufacturing of high-value, non-commoditized Active Pharmaceutical Ingredients (APIs) for chronic therapeutic areas. Established in 2011, the company operates as one of India's premier private sector enterprises in the pharmaceuticals sector and is listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) under the symbol ALIVUS.